AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
AAPL   321.44 (+1.05%)
MSFT   182.42 (+0.33%)
FB   229.57 (+0.19%)
GOOGL   1,432.17 (+0.84%)
AMZN   2,422.84 (+0.52%)
NVDA   347.14 (+1.80%)
BABA   200.25 (-0.46%)
GE   7.08 (-2.88%)
TSLA   818.12 (-0.26%)
AMD   53.36 (+1.18%)
T   31.51 (-1.10%)
ACB   16.37 (+6.99%)
DIS   118.72 (-2.31%)
NFLX   421.09 (+0.29%)
BAC   25.23 (-2.89%)
BA   154.53 (+3.35%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 bluebird bioCrispr TherapeuticsAudentes TherapeuticsAllogene TherapeuticsHalozyme Therapeutics
SymbolNASDAQ:BLUENASDAQ:CRSPNASDAQ:BOLDNASDAQ:ALLONASDAQ:HALO
Price Information
Current Price$63.09$63.72$59.97$48.92$24.10
52 Week RangeBuyBuyHoldBuyBuy
Beat the Market™ Rank
Overall Score1.61.40.91.32.2
Analysis Score4.43.41.12.33.4
Community Score3.02.52.62.32.6
Dividend Score0.00.00.00.00.0
Ownership Score0.01.01.02.03.0
Earnings & Valuation Score0.60.00.00.01.9
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$115.47$74.42$50.75$39.09$28.63
% Upside from Price Target83.02% upside16.80% upside-15.37% downside-20.09% downside18.78% upside
Trade Information
Market Cap$3.56 billion$3.89 billion$2.77 billion$6.19 billion$3.29 billion
Beta2.382.262.181.71.75
Average Volume1,796,3651,019,7411,504,3891,566,5851,526,671
Sales & Book Value
Annual Revenue$44.67 million$289.59 millionN/AN/A$195.99 million
Price / Sales78.6013.43N/AN/A16.70
CashflowN/A$1.25 per shareN/AN/AN/A
Price / CashN/A51.15N/AN/AN/A
Book Value$20.13 per share$14.52 per share($7.48) per share$4.84 per share$0.43 per share
Price / Book3.134.39N/AN/A56.05
Profitability
Net Income$-789,610,000.00$66.86 million$-128,820,000.00$-184,590,000.00$-72,240,000.00
EPS($14.31)$1.17($3.40)($1.83)($0.50)
Trailing P/E RatioN/A84.96N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A15.45
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-1,531.04%15.73%N/AN/A-48.75%
Return on Equity (ROE)-60.05%6.54%N/A-33.05%-48.92%
Return on Assets (ROA)-46.17%5.54%-38.00%-29.27%-17.36%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.16%N/AN/A0.08%6.66%
Current Ratio5.25%16.87%12.80%18.81%11.14%
Quick Ratio5.25%16.87%12.79%18.81%10.15%
Ownership Information
Institutional Ownership PercentageN/A57.96%96.33%57.93%95.37%
Insider Ownership Percentage3.00%21.40%5.30%36.50%2.60%
Miscellaneous
Employees1,090188207122281
Shares Outstanding55.65 million61.02 million46.27 million125.33 million135.82 million
Next Earnings Date8/6/2020 (Estimated)8/3/2020 (Estimated)N/A8/5/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.